Dr. Tsay Brings Two Decades of Expertise in
Clinical Medicine, Research, and Health Technology to Cue
SAN
DIEGO, Sept. 8, 2022 /PRNewswire/ -- Cue Health
Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today
announced that it has appointed David
Tsay, MD, PhD, as its Chief Medical Officer. Dr. Tsay comes
to Cue with more than 20 years of experience in clinical medicine,
research, and health technology. Most recently, Dr. Tsay served at
Apple, where he led an Apple Health clinical team in developing new
Health products, including FDA-cleared products in cardiovascular
health.
As Chief Medical Officer, Dr. Tsay will help define future Cue
diagnostic products and services. Dr. Tsay will also lead
engagement across a wide range of healthcare stakeholders, driving
communication, collaboration, and ecosystem alignment in support of
Cue's healthcare initiatives.
Prior to Apple, Dr. Tsay served as Associate Chief
Transformation Officer at New York-Presbyterian (NYP), one of the
nation's most comprehensive academic healthcare delivery systems.
He led digital transformation initiatives for NYP, including
overseeing enterprise teams for data science, business
intelligence, artificial intelligence, automation, and digital
web/mobile technologies. During his tenure at NYP, Dr. Tsay also
served as an Assistant Clinical Professor of Medicine at
Columbia University Medical Center. He
was previously a founding team member for NYP OnDemand, a
comprehensive suite of digital health services.
"We are delighted to have Dr. Tsay join us as our Chief Medical
Officer. We believe Dr. Tsay will play a key role in shaping the
advanced healthcare technologies we are creating at Cue, where
diagnostics and software-supported health journeys can lead to
better clinical outcomes across a variety of disease categories,"
said Ayub Khattak, Chairman and CEO
of Cue Health. "Dr. Tsay has the clinical experience, proven
leadership ability, and key relationships to make a meaningful and
lasting impact at Cue as well as in the lives of the patients and
providers we serve."
"I look forward to working alongside Cue's executive leadership
team as the company's products evolve into a more comprehensive
platform that empowers stakeholders across the healthcare ecosystem
with faster and more accurate diagnostic information," added Dr.
Tsay. "The democratization of diagnostic testing can not only
transform care paradigms but also ultimately help improve health
outcomes."
Dr. Tsay received his BA in Computer Science and Physics from
Columbia University College, and
subsequently his MD and PhD degrees from Columbia University College of Physicians and
Surgeons. He is board certified in internal medicine and
cardiology and holds active medical licenses in both California and New
York.
About Cue Health
Cue Health (Nasdaq: HLTH) is a
healthcare technology company that makes it easy for individuals to
access health information and places diagnostic information at the
center of care. Cue Health enables people to manage their health
through real-time, actionable, and connected health information,
offering individuals and their healthcare providers easy access to
lab-quality diagnostics anywhere, anytime, in a device that fits in
the palm of the hand. Cue Health's first-of-its-kind COVID-19 test
was the first FDA-authorized molecular diagnostic test for at-home
and over-the-counter use without a prescription and physician
supervision. Outside the United
States, Cue Health has received the CE mark in the European
Union, Interim Order authorization from Health Canada, regulatory
approval from India's Central
Drugs Standard Control Organization, and PSAR authorization from
Singapore's Health Sciences
Authority. Cue was founded in 2010 and is headquartered in
San Diego. For more information,
please visit www.cuehealth.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/cue-health-appoints-david-tsay-md-phd-as-chief-medical-officer-301620296.html
SOURCE Cue Health Inc.